FDA Approval: The FDA granted full approval for Symvess on December 19, 2024 for use in adults as a vascular conduit for extremity arterial injury when urgent revascularization is needed to avoid ...

Jeffrey Graves; President, Chief Executive Officer, Director; 3D Systems Corp Jeffrey Creech; Chief Financial Officer, Executive Vice President; 3D Systems Corp Greetings, and welcome to the 3D ...

Operator Greetings and welcome to the 3D Systems fourth quarter and fiscal year 2024 earnings conference call and webcast. At ...

At present, Vantage has deployed its wooden structures in Hungary and Germany, where, in October 2023, the company announced ...

Watch the video above to see the full episode of Catalysts from March 6, 2025. To watch more expert insights and analysis on ...

We created novel artificial cells by encapsulating a riboswitch-gene fusion with wheat germ extract in liposomes. These ...

McCormick is working to reformulate products to remove certain ingredients like food dyes that have been scrutinized by ...

CHARLESTON, W.Va. (AP) — Synthetic dyes used to make brightly colored cereals, drinks and candies are coming under scrutiny ...

Integra Resources Corp. ( NYSE: ITRG) Q4 2024 Earnings Conference Call March 27, 2025 11:00 AM ET Jason Banducci - VP, Corporate Development and IR George Salamis - President, CEO and Director Greg ...

Urteste plans to start clinical trials for its pancreatic cancer test in Europe in Q3 2025 ...

Tesla is America's electric car juggernaut; a domestic force that helped to push EV adoption all across the globe—something ...

Slideshows ...